Researchers from the San Raffaele Telethon Institute for Gene Therapy assessed a liver-directed lentiviral vector gene therapy in a mouse model of methylmalonic acidemia and in patient-derived human fibroblasts. The work evaluated efficacy with an eye toward durability and translational relevance for a monogenic metabolic disorder.